GlucaGen regulatory update

Health Canada approved an NDS from Novo Nordisk for GlucaGen to treat severe hypoglycemia in diabetic patients being treated with insulin. Paladin Labs Inc. (TSX:PLB, Montreal, Quebec), which has rig...